医学
移植
重症监护医学
随机对照试验
羟乙基淀粉
肾移植
生理盐水
中心静脉压
高钾血症
外科
麻醉
血压
内科学
心率
作者
Gebhard Wagener,Dmitri Bezinover,Cynthia Wang,Elizabeth Kroepfl,Geraldine C. Diaz,Chris Giordano,James M. West,James D. Kindscher,Marina Moguilevitch,Ramona Nicolau‐Raducu,Raymond M. Planinsic,David M. Rosenfeld,Scott A Lindberg,Roman Schumann,Evan G. Pivalizza
出处
期刊:Transplantation
[Ovid Technologies (Wolters Kluwer)]
日期:2021-07-20
卷期号:105 (8): 1677-1684
被引量:27
标识
DOI:10.1097/tp.0000000000003581
摘要
Intraoperative fluid management may affect the outcome after kidney transplantation. However, the amount and type of fluid administered, and monitoring techniques vary greatly between institutions and there are limited prospective randomized trials and meta-analyses to guide fluid management in kidney transplant recipients.Members of the American Society of Anesthesiologists (ASA) committee on transplantation reviewed the current literature on the amount and type of fluids (albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different monitors used to assess fluid status, resulting in this consensus statement with recommendations based on the best available evidence.Review of the current literature suggests that starch solutions are associated with increased risk of renal injury in randomized trials and should be avoided in kidney donors and recipients. There is no evidence supporting the routine use of albumin solutions in kidney transplants. Balanced crystalloid solutions such as Lactated Ringer are associated with less acidosis and may lead to less hyperkalemia than 0.9% saline solutions. Central venous pressure is only weakly supported as a tool to assess fluid status.These recommendations may be useful to anesthesiologists making fluid management decisions during kidney transplantation and facilitate future research on this topic.
科研通智能强力驱动
Strongly Powered by AbleSci AI